These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3981034

  • 21. Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
    Kavian N, Marut W, Servettaz A, Laude H, Nicco C, Chéreau C, Weill B, Batteux F.
    J Immunol; 2012 May 15; 188(10):5142-9. PubMed ID: 22491256
    [Abstract] [Full Text] [Related]

  • 22. The effect of T cell depletion from spleen cell allografts on graft-versus-host disease and long-term immune reconstitution in H-2 haplotype-identical murine combinations.
    Tokuda N, Mayumi H, Sakumoto M, Himeno K, Tomita Y, Nomoto K.
    Immunobiology; 1989 Oct 15; 179(4-5):328-41. PubMed ID: 2515151
    [Abstract] [Full Text] [Related]

  • 23. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W, Kim J, Jung D, Kim H, Choi HJ, Cho HR, Kwon B.
    Biol Blood Marrow Transplant; 2009 Mar 15; 15(3):306-14. PubMed ID: 19203721
    [Abstract] [Full Text] [Related]

  • 24. CD137 in chronic graft-versus-host disease.
    Kim J, Cho HR, Kwon B.
    Methods Mol Biol; 2014 Mar 15; 1155():95-108. PubMed ID: 24788176
    [Abstract] [Full Text] [Related]

  • 25. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Zhou L, Askew D, Wu C, Gilliam AC.
    J Invest Dermatol; 2007 Feb 15; 127(2):281-92. PubMed ID: 16917493
    [Abstract] [Full Text] [Related]

  • 26. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T, Holda JH, Claman HN.
    J Immunol; 1985 Sep 15; 135(3):1644-51. PubMed ID: 3160774
    [Abstract] [Full Text] [Related]

  • 27. Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.
    Cleveland MG, Lane RG, Klimpel GR.
    Cell Immunol; 1987 Nov 15; 110(1):120-30. PubMed ID: 3119228
    [Abstract] [Full Text] [Related]

  • 28. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
    Lim JY, Ryu DB, Lee SE, Park G, Min CK.
    J Invest Dermatol; 2017 Sep 15; 137(9):1895-1904. PubMed ID: 28526296
    [Abstract] [Full Text] [Related]

  • 29. Preventive effect of ultraviolet radiation on murine chronic sclerodermatous graft-versus-host disease.
    Mermet I, Kleinclauss F, Marandin A, Guérrini JS, Angonin R, Tiberghien P, Saas P, Aubin F.
    Transplantation; 2007 Dec 27; 84(12):1696-700. PubMed ID: 18165783
    [Abstract] [Full Text] [Related]

  • 30. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST, Gleichmann H, Gleichmann E.
    J Exp Med; 1984 Feb 01; 159(2):508-23. PubMed ID: 6229596
    [Abstract] [Full Text] [Related]

  • 31. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
    Holda JH, Maier T, Claman HN.
    J Immunol; 1985 Mar 01; 134(3):1397-402. PubMed ID: 3155767
    [Abstract] [Full Text] [Related]

  • 32. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
    McCormick LL, Zhang Y, Tootell E, Gilliam AC.
    J Immunol; 1999 Nov 15; 163(10):5693-9. PubMed ID: 10553100
    [Abstract] [Full Text] [Related]

  • 33. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K.
    J Immunol; 1994 Nov 01; 153(9):4311-20. PubMed ID: 7930630
    [Abstract] [Full Text] [Related]

  • 34. Acute and chronic graft-versus-host disease induced by minor histocompatibility antigens in mice.
    Hamilton BL, Parkman R.
    Transplantation; 1983 Aug 01; 36(2):150-5. PubMed ID: 6349039
    [Abstract] [Full Text] [Related]

  • 35. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
    Dey B, Yang YG, Preffer F, Shimizu A, Swenson K, Dombkowski D, Sykes M.
    Transplantation; 1999 Jul 15; 68(1):141-9. PubMed ID: 10428282
    [Abstract] [Full Text] [Related]

  • 36. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L, Guiffre A, Atkinson K, Rainer SP, Sewell WA.
    Bone Marrow Transplant; 2002 Jan 15; 29(2):151-8. PubMed ID: 11850710
    [Abstract] [Full Text] [Related]

  • 37. Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
    Liu C, Yang X, Zhu P, Fujino M, Ito H, Takahashi K, Nakajima M, Tanaka T, Wang J, Zhuang J, Zou H, Li XK.
    Exp Dermatol; 2018 Oct 15; 27(10):1104-1111. PubMed ID: 29978518
    [Abstract] [Full Text] [Related]

  • 38. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease.
    Howell CD, Yoder T, Claman HN, Vierling JM.
    J Immunol; 1989 Jul 15; 143(2):476-83. PubMed ID: 2472440
    [Abstract] [Full Text] [Related]

  • 39. Murine graft-versus-host skin disease: a chronologic and quantitative analysis of two histologic patterns.
    Charley MR, Bangert JL, Hamilton BL, Gilliam JN, Sontheimer RD.
    J Invest Dermatol; 1983 Nov 15; 81(5):412-7. PubMed ID: 6631052
    [Abstract] [Full Text] [Related]

  • 40. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K, Schick J, Wehrmann M, Wollny G, Simon P, Schlegel PG, Eyrich M.
    Transplantation; 2007 Jul 27; 84(2):214-22. PubMed ID: 17667813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.